Lawrence Rice

Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition.

Youli Zu, Chung-Che Chang, Jianguo Wen, 2010, Leukemia research.

P38 MAPK inhibition enhancing ATO‐induced cytotoxicity against multiple myeloma cells

Youli Zu, Jianguo Wen, Albert Mo, 2007, British journal of haematology.